On this page

JUNIOR STRENGTH ADVIL

ibuprofen · Tablet, Chewable

Over-the-counter NDA Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
JUNIOR STRENGTH ADVIL
Generic name
ibuprofen
Dosage form
Tablet, Chewable
Route
Oral
Marketing category
NDA · NDA
Labeler
Proficient Rx LP
Product type
Human Otc Drug
DEA schedule
Not scheduled
Active ingredients
1
NDC product codes
2
Packages
2
Data completeness
76% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Ibuprofen 100 mg/1 310965 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Tablet, Chewable
Route of administration
Oral
Presentations
4

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory
Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class Type Browse
Anti-Inflammatory Agents EPC All 251 members
Cyclooxygenase Inhibitors [MoA] MoA All 251 members
Non-Steroidal [CS] CS All 251 members
Nonsteroidal Anti-inflammatory Drug [EPC] EPC All 251 members

Regulatory status

Source: Drugs@FDANDC Directory
Application number
020944
Application type
NDA · New Drug Application
Approval date
December 18, 1998
Sponsor
HALEON US HOLDINGS
Products on application
2
Submissions recorded
10
Products approved under application 020944.
Product Trade name Form Strength Ingredient Status TE Flags
020944-001 CHILDREN'S ADVIL TABLET, CHEWABLE IBUPROFEN Over-the-counter —
020944-002 JUNIOR STRENGTH ADVIL TABLET, CHEWABLE IBUPROFEN Over-the-counter —

Approval history

Source: Drugs@FDA
Most recent submissions on application 020944.
Type No. Action Status Date Review
Supplement 17 Labeling Approved May 1, 2026 Standard
Supplement 13 Labeling Approved December 26, 2017 Standard
Supplement 11 Labeling Approved March 27, 2017 Standard
Supplement 10 Manufacturing (CMC) Approved February 13, 2014 —
Supplement 8 Labeling Approved May 19, 2009 Standard
Supplement 6 Labeling Approved June 11, 2008 Standard
Supplement 5 Labeling Approved April 4, 2006 Standard
Supplement 3 Labeling Approved December 20, 2004 Standard
Supplement 2 Labeling Approved December 20, 2004 Standard
Original application 1 Type 3 - New Dosage Form Approved December 18, 1998 Standard

Review documents

  • 0 · Supplement · May 4, 2026
  • 0 · Supplement · March 29, 2017
  • 0 · Supplement · March 28, 2017
  • 0 · Supplement · April 18, 2013
  • 0 · Supplement · April 18, 2013
  • 0 · Supplement · May 27, 2009
  • 0 · Supplement · June 13, 2008
  • 0 · Supplement · April 7, 2006
  • 0 · Supplement · December 30, 2004
  • 0 · Supplement · December 30, 2004
  • 0 · Original application · May 26, 2004
  • 0 · Original application · December 18, 1998
  • 0 · Original application · December 18, 1998

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20200301). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN OTC DRUG · 20200301

Indications and Usage

openFDA Drug Labeling

USES temporarily: • reduces fever • relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches

PURPOSE Fever reducer/Pain reliever

Dosage and Administration

openFDA Drug Labeling

DIRECTIONS • this product does not contain directions or complete warnings for adult use • do not give more than directed • find right dose on chart. If possible, use weight to dose; otherwise use age. • repeat dose every 6-8 hours , if needed • do not use more than 4 times a day Dosing Chart Weight (lb) Age (yr) Dose (tablets) under 24 lb under 2 yr ask a doctor 24-35 lb 2-3 yr 1 tablet 36-47 lb 4-5 yr 1 1⁄2 tablets 48-59 lb 6-8 yr 2 tablets 60-71 lb 9-10 yr 2 1⁄2 tablets 72-95 lb 11 yr 3 tablets

WARNINGS Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: • hives • facial swelling • asthma (wheezing) • shock • skin reddening • rash • blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if the child • has had stomach ulcers or bleeding problems • takes a blood thinning (anticoagulant) or steroid drug • takes other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others] • takes more or for a longer time than directed Heart attack and stroke warning NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Sore throat warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult doctor promptly. Do not use more than 2 days or administer to children under 3 years of age unless directed by doctor. Do not use • if the child has ever had an allergic reaction to any other pain reliever/fever reducer • right before or after heart surgery Ask a doctor before use if • stomach bleeding warning applies to the child • child has problems or serious side effects from taking pain relievers or fever reducers • child has a history of stomach problems, such as heartburn • child has high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke • child has not been drinking fluids • child has lost a lot of fluid due to vomiting or diarrhea • child is taking a diuretic Ask a doctor or pharmacist before use if the child is • under a doctor's care for any serious condition • taking any other drug When using this product • take with food or milk if stomach upset occurs Stop use and ask a doctor if • child experiences any of the following signs of stomach bleeding: • feels faint • vomits blood • has bloody or black stools • has stomach pain that does not get better • child has symptoms of heart problems or stroke: • chest pain • trouble breathing • weakness in one part or side of body • slurred speech • leg swelling • child does not get any relief within first day (24 hours) of treatment • fever or pain gets worse or lasts more than 3 days • redness or swelling is present in the painful area • any new symptoms appear Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use • if the child has ever had an allergic reaction to any other pain reliever/fever reducer • right before or after heart surgery

Ask a Doctor

openFDA Drug Labeling

Ask a doctor before use if • stomach bleeding warning applies to the child • child has problems or serious side effects from taking pain relievers or fever reducers • child has a history of stomach problems, such as heartburn • child has high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke • child has not been drinking fluids • child has lost a lot of fluid due to vomiting or diarrhea • child is taking a diuretic

Stop use and ask a doctor if • child experiences any of the following signs of stomach bleeding: • feels faint • vomits blood • has bloody or black stools • has stomach pain that does not get better • child has symptoms of heart problems or stroke: • chest pain • trouble breathing • weakness in one part or side of body • slurred speech • leg swelling • child does not get any relief within first day (24 hours) of treatment • fever or pain gets worse or lasts more than 3 days • redness or swelling is present in the painful area • any new symptoms appear

Active Ingredient

openFDA Drug Labeling

ACTIVE INGREDIENT (IN EACH TABLET) Ibuprofen 100 mg (NSAID)* *nonsteroidal anti-inflammatory drug

Adverse event reports

Source: openFDA FAERS
283,546
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: IBUPROFEN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
0573-0179-20 0573-0179 Haleon US Holdings LLC 1 BOTTLE in 1 CARTON (0573-0179-20) / 24 TABLET, CHEWABLE in 1 BOTTLE June 1, 2011
71205-425-24 71205-425 Proficient Rx LP 1 BOTTLE in 1 CARTON (71205-425-24) / 24 TABLET, CHEWABLE in 1 BOTTLE March 11, 2020
0573-0179 0573-0179 Haleon US Holdings LLC — June 1, 2011
71205-425 71205-425 Proficient Rx LP — June 1, 2011

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts

Generated September 25, 2026 · 10 sections on this page.